JP2015518837A5 - - Google Patents

Download PDF

Info

Publication number
JP2015518837A5
JP2015518837A5 JP2015512890A JP2015512890A JP2015518837A5 JP 2015518837 A5 JP2015518837 A5 JP 2015518837A5 JP 2015512890 A JP2015512890 A JP 2015512890A JP 2015512890 A JP2015512890 A JP 2015512890A JP 2015518837 A5 JP2015518837 A5 JP 2015518837A5
Authority
JP
Japan
Prior art keywords
compound
salt
formula
process according
forming
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015512890A
Other languages
English (en)
Japanese (ja)
Other versions
JP6214636B2 (ja
JP2015518837A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2013/041624 external-priority patent/WO2013173736A1/en
Publication of JP2015518837A publication Critical patent/JP2015518837A/ja
Publication of JP2015518837A5 publication Critical patent/JP2015518837A5/ja
Application granted granted Critical
Publication of JP6214636B2 publication Critical patent/JP6214636B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015512890A 2012-05-17 2013-05-17 ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス Active JP6214636B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201261648421P 2012-05-17 2012-05-17
US61/648,421 2012-05-17
US201361785281P 2013-03-14 2013-03-14
US61/785,281 2013-03-14
PCT/US2013/041624 WO2013173736A1 (en) 2012-05-17 2013-05-17 Process for making hydroxylated cyclopentylpyrimidine compounds

Publications (3)

Publication Number Publication Date
JP2015518837A JP2015518837A (ja) 2015-07-06
JP2015518837A5 true JP2015518837A5 (enExample) 2016-07-07
JP6214636B2 JP6214636B2 (ja) 2017-10-18

Family

ID=48534507

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015512890A Active JP6214636B2 (ja) 2012-05-17 2013-05-17 ヒドロキシル化シクロペンチルピリミジン化合物を作製するためのプロセス

Country Status (18)

Country Link
US (1) US9309204B2 (enExample)
EP (1) EP2861583B1 (enExample)
JP (1) JP6214636B2 (enExample)
KR (1) KR20150020211A (enExample)
CN (1) CN104487430B (enExample)
AU (1) AU2013262568B2 (enExample)
BR (1) BR112014028570A2 (enExample)
CA (1) CA2873653A1 (enExample)
DK (1) DK2861583T3 (enExample)
ES (1) ES2588878T3 (enExample)
IL (1) IL235714A0 (enExample)
MA (1) MA37649B1 (enExample)
MX (1) MX2014013865A (enExample)
PL (1) PL2861583T3 (enExample)
RU (1) RU2014151017A (enExample)
SG (1) SG11201407613RA (enExample)
SI (1) SI2861583T1 (enExample)
WO (1) WO2013173736A1 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2858989T3 (da) 2012-05-17 2020-06-02 Genentech Inc Amorf form af en AKT-hæmmende pyrimidinyl-cyclopentan-forbindelse, sammensætninger deraf og fremgangsmåder dertil
KR102123131B1 (ko) 2012-05-17 2020-06-15 제넨테크, 인크. 하이드록실화 사이클로펜타피리미딘 화합물 및 이의 염의 제조 방법
CN104520263B (zh) 2012-05-17 2016-11-09 基因泰克公司 制备氨基酸化合物的方法
DK2861582T3 (en) 2012-05-17 2016-08-22 Array Biopharma Inc A process for preparing hydroxylated compounds cyclopentylpyrimidin
HRP20231100T1 (hr) 2013-11-15 2023-12-22 F. Hoffmann - La Roche Ag Postupci za proizvodnju pirimidinilciklopentan spojeva
KR102284938B1 (ko) * 2013-11-27 2021-08-02 선샤인 레이크 파르마 컴퍼니 리미티드 다이하이드로피리미딘 유도체 및 이의 중간산물의 제조 방법
SG10201806450SA (en) 2014-09-26 2018-09-27 Hoffmann La Roche PROCESSES FOR PREPARING (CYCLOPENTYL[d]PYRIMIDIN-4-YL)PIPERAZINE COMPOUNDS
CA3175354A1 (en) 2020-06-16 2021-12-23 F. Hoffmann-La Roche Ag Process for making hydroxylated cyclopentylpyrimidine compounds
KR102689151B1 (ko) * 2021-09-06 2024-07-29 연세대학교 산학협력단 Akt 신호경로 억제제를 유효성분으로 포함하는 아토피피부염의 예방 또는 치료용 조성물

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2178829A1 (en) 1993-12-12 1995-06-15 Yigal Cohen A novel method to protect plants from fungal infection
EP0973396A4 (en) 1997-04-07 2001-02-07 Merck & Co Inc METHOD FOR TREATING CANCER
US6201023B1 (en) 1997-06-10 2001-03-13 Agrogene Ltd. Methods and compositions to protect crops against plant parasitic nematodes
EP0982300A3 (en) 1998-07-29 2000-03-08 Societe Civile Bioprojet Non-imidazole alkylamines as histamine H3 - receptor ligands and their therapeutic applications
CA2363169A1 (en) 1999-03-03 2000-09-08 Merck & Co., Inc. Inhibitors of prenyl-protein transferase
AU766079B2 (en) 1999-06-03 2003-10-09 Teikoku Hormone Mfg. Co., Ltd. Substituted pyrazole compounds
WO2001022963A1 (en) 1999-09-27 2001-04-05 Merck & Co., Inc. Method of preventing osteoporosis
WO2004108673A2 (en) 2003-06-09 2004-12-16 Boehringer Ingelheim International Gmbh Inhibitors of papilloma virus
US20050130954A1 (en) 2003-11-21 2005-06-16 Mitchell Ian S. AKT protein kinase inhibitors
US8927546B2 (en) 2006-02-28 2015-01-06 Dart Neuroscience (Cayman) Ltd. Therapeutic piperazines
UA95641C2 (xx) * 2006-07-06 2011-08-25 Эррей Биофарма Инк. Гідроксильовані піримідильні циклопентани як інгібітори акт протеїнкінази$гидроксилированные пиримидильные циклопентаны как ингибиторы акт протеинкиназы
US8063050B2 (en) * 2006-07-06 2011-11-22 Array Biopharma Inc. Hydroxylated and methoxylated pyrimidyl cyclopentanes as AKT protein kinase inhibitors
JP5157576B2 (ja) 2007-05-14 2013-03-06 住友化学株式会社 光学活性2−アルキル−1,1,3−トリアルコキシカルボニルプロパンの製造方法
SI2173723T1 (sl) * 2007-07-05 2011-12-30 Array Biopharma Inc Pirimidil ciklopentani kot inhibitorji AKT-protein-kinaze
US20100298289A1 (en) 2007-10-09 2010-11-25 Ucb Pharma, S.A. Heterobicyclic compounds as histamine h4-receptor antagonists
JP5346345B2 (ja) * 2008-01-09 2013-11-20 アレイ バイオファーマ、インコーポレイテッド Aktタンパク質キナーゼ阻害剤としての水酸化されたピリミジルシクロペンタン類
US8748462B2 (en) * 2008-10-15 2014-06-10 Amgen Inc. Spirocyclic GPR40 modulators
EP2419404B1 (en) 2009-04-15 2015-11-04 AbbVie Inc. Anti-viral compounds
AU2010310786B2 (en) 2009-10-23 2014-03-27 Eli Lilly And Company AKT inhibitors
US9050334B2 (en) 2010-07-16 2015-06-09 Innov88 Llc MIF inhibitors and their uses
WO2012177925A1 (en) 2011-06-21 2012-12-27 The Board Institute, Inc. Akt inhibitors for treating cancer expressing a magi3 - akt3 fusion gene
DK2861582T3 (en) 2012-05-17 2016-08-22 Array Biopharma Inc A process for preparing hydroxylated compounds cyclopentylpyrimidin
KR102123131B1 (ko) 2012-05-17 2020-06-15 제넨테크, 인크. 하이드록실화 사이클로펜타피리미딘 화합물 및 이의 염의 제조 방법
CN104520263B (zh) 2012-05-17 2016-11-09 基因泰克公司 制备氨基酸化合物的方法
CA2889855A1 (en) 2012-11-01 2014-05-08 Robert S. Katz Methods for treating fibromyalgia
EP2956441A4 (en) 2013-02-18 2016-11-02 Scripps Research Inst MODULATORS OF VASOPRESSIN RECEPTORS WITH THERAPEUTIC POTENTIAL
US10131637B2 (en) 2013-03-15 2018-11-20 Shifa Biomedical Corporation Anti-PCSK9 compounds and methods for the treatment and/or prevention of cardiovascular diseases

Similar Documents

Publication Publication Date Title
RU2014151017A (ru) Способ получения гидроксилированных циклопентилпиримидинов
JP2012506425A5 (enExample)
JP2016520672A5 (enExample)
JP2015524409A5 (enExample)
JP2012140458A5 (enExample)
JP2015512868A5 (ja) ビニルエステル及び酢酸又はプロピオン酸反応生成物の共製造の第一段階としてのトランスビニル化
JP2014511367A5 (enExample)
JP2013147496A5 (ja) 有機金属錯体
JP2015516945A5 (enExample)
JP2012092103A5 (enExample)
JP2016515039A5 (enExample)
RU2019119584A (ru) Способ получения триазолопиридинового соединения
JP2015520165A5 (enExample)
JP2015517532A5 (enExample)
JP2017509581A5 (enExample)
HRP20180948T1 (hr) Postupak za proizvodnju aminokiselinskih spojeva
JP2018009003A5 (enExample)
JP2016539168A5 (enExample)
JP2013241421A5 (enExample)
MX384252B (es) Proceso para sintesis de pirfenidona.
HRP20191632T1 (hr) Kemijski postupak dobivanja spiroindolona i njihovih međuprodukata
IN2013MN02407A (enExample)
RU2016112136A (ru) Способ получения 1,1-дибром-1-фторэтана
JP2015536305A5 (enExample)
MY169321A (en) Compositions